The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials

Recent studies suggest that the ability to produce equol, a metabolite of the soya isoflavone daidzein, is beneficial to coronary health. Equol, generated by bacterial action on isoflavones in the human gut, is biologically more potent than dietary sources of isoflavones. Not all humans are equol pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Birru, Rahel L., Ahuja, Vasudha, Vishnu, Abhishek, Evans, Rhobert W., Miyamoto, Yoshihiro, Miura, Katsuyuki, Usui, Takeshi, Sekikawa, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976117/
https://www.ncbi.nlm.nih.gov/pubmed/27547393
http://dx.doi.org/10.1017/jns.2016.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976117/
https://www.ncbi.nlm.nih.gov/pubmed/27547393
http://dx.doi.org/10.1017/jns.2016.18

Ejemplares similares